
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

September 26, 2023
Waltham, MA — Cytel Inc., provider of quantitative insights and health data analytics to leaders in the life sciences,...
Read article

July 6, 2023
Cytel Acquires stève consultants to Further Expand Real-World Analytics
Waltham, MA, July 06, 2023 – Cytel Inc., provider of quantitative insights and health data analytics to leaders in life...
Read article

May 8, 2023
Cytel’s strategic consulting expands offering and forms new Therapeutics Development Team
Cytel brings together Quantitative, Computational, Regulatory, and Strategic Drug Development Capabilities into Modern...
Read article

February 7, 2023
Cytel and GSK Partner to Advance Clinical Trial Design with Solara
GSK plans expansion of Solara clinical trial strategy platform to optimize design selection across therapeutic areas
Read article

January 12, 2023
Announcing the Launch of the Cytel Design Institute
WALTHAM, MASSACHUSETTS — Cytel Inc., a leading provider of innovative clinical trial designs, advanced analytics, and...
Read article

November 16, 2022
Cytel’s Solara wins 2022 Fierce Innovation Award
Solara clinical trial strategy platform recognized for transformative innovation WALTHAM, MASS - Cytel Inc., a...
Read article

October 13, 2022
Cytel to acquire SDS Life Science and SDS MedteQ to enhance and expand thought-leadership in strategic therapeutics development
Waltham, MA, October 13, 2022 – Cytel Inc., provider of quantitative insights and health data analytics to leaders in...
Read article

September 6, 2022
Cytel expansion unlocks innovative clinical development expertise for APAC biopharma sector
WALTHAM, MASS - Cytel Inc., a pioneer of adaptive clinical trial design and provider of advanced biometrics services,...
Read article

July 5, 2022
Cytel and Roche Pioneer New Bias Adjustment Method
WALTHAM, MASS - Cytel Inc. and F. Hoffman-La Roche Ltd., have partnered together to pioneer the application of a unique...
Read article

May 17, 2022
Cytel designed and led TOGETHER Trial wins Society of Clinical Trial
WALTHAM, MASS - The TOGETHER Trial for COVID-19 therapies, designed by clinical trial specialists at Cytel Inc., has...
Read article

April 27, 2022
Presentation at ISPOR 2022 Detailing Covid-19 Impact on Breast Cancer
Joint efforts recognize the global pandemic impact on the staging of cancer cases in the United States at the...
Read article

March 22, 2022
Analytics and Innovation Available to Clinicians in Drug Development
WALTHAM, MASS - Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving...
Read article

September 13, 2021
Fluvoxamine COVID benefits discovered using Cytel-designed platform
Using Cytel’s expertise, the TOGETHER Trial simultaneously tests multiple repurposed therapies
Read article

May 27, 2021
Statistical Innovation to be Mobilized for Global Health Challenges
Cytel and its collaborators have analyzed the challenges of conducting high-quality clinical research in LMICs – a...
Read article

May 6, 2021
New Strategy & Innovation to Further Drive Bayesian Innovation
WALTHAM, MASS - Cytel Inc. is pleased to announce that renowned Bayesian clinical trial design specialist Dr Kyle...
Read article

March 29, 2021
General Release of Solara & New Trial Optimization Program for Biotechs
WALTHAM, MASS - After months of successfully deploying its new strategic decision-support software Solara, Cytel Inc.,...
Read article

October 6, 2020
Cytel ushers in new era of optimized clinical trial design
Waltham, MA, October 6, 2020 – Cytel Inc. has launched SolaraTM, a collaborative decision-support platform that...
Read article

September 21, 2020
Cytel expands unique trial for early COVID-19 treatments in Global South
Two South Africa sites added to TOGETHER platform trials for the outpatient treatment of high-risk adults infected with...
Read article

September 3, 2020
Cytel acquires Laiya Consulting
Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in...
Read article

July 22, 2020
East Alloy for easy access to verified Bayesian and innovative methods
Cytel Inc., an advanced
Read article

October 17, 2019
Cytel to hold Complex Innovative Trial Design Symposium
Cytel Inc., the leading global provider of innovative analytical software and consulting services to the life sciences...
Read article

January 7, 2019
Cytel Names Joshua Schultz as Chief Executive Officer
Cytel announced the appointment of Joshua Schultz as Chief Executive Officer (CEO) effective January 7th, 2019. He...
Read article

January 1, 2019
Cytel Transforms Biopharmaceutical Go/No-Go Decision-Making
Cytel announced the launch of OK GO, the first commercially available software to underpin quantitative go/no-go...
Read article

December 17, 2018
Cytel Wins Best CRO- Specialist Provider at 2018 Scrip Awards
Cytel has won Best Contract Research Organization( CRO) – Specialist Providers at the 2018 Scrip Awards. The accolade...
Read article

December 15, 2018
Cytel Announces Launch of East 6.5
Cytel Inc., a global provider of advanced analytical solutions to the pharmaceutical, biotechnology, and medical device...
Read article

March 1, 2018
Cytel Launch of East Lite App for Sample Size Calculations on the Go
Cytel announces the launch of its East Lite app on iOS. Developed by the team responsible for East, East Lite features...
Read article

February 1, 2018
Congratulates Lipopharma and CLINGLIO Consortium on Recent Grant Award
Congratulations to Lipopharma and the CLINGLIO project consortium on their recent 6,15M€ grant award by the European...
Read article